AQIX RS-I - Basic development of a therapeutic formulation for the assessment and regeneration of donor organs otherwise regarded as marginal for transplantation
Lead Participant:
AQIX LIMITED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| AQIX LIMITED | £267,900 | £ 160,740 |
Participant |
||
| FREEMAN HOSPITAL | £131,843 | £ 131,843 |
People |
ORCID iD |